Mechanistic comparison of Ornipressin and Vasopressins Antidiuretic hormones released by based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
4
Shared Targets
67%
Jaccard Similarity
68%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Ornipressin and Vasopressins share 4 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.667 means 67% of the combined target set is bound by both compounds. The IDF-weighted score of 0.681 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Ornipressin and Vasopressins have in common?
Ornipressin and Vasopressins share 4 molecular targets with a Jaccard similarity of 67%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Ornipressin and Vasopressins be combined?
Ornipressin and Vasopressins share 4 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Ornipressin or Vasopressins?
In the BiohacksAI corpus: Ornipressin has 82 PubMed-indexed studies, Vasopressins has 300 studies.